Eterna Therapeutics Inc (ERNA) Stock Price

6.80 ▼ -0.59 (-7.98%)
Open: 7.8361 Vol: 57.04K Day's range: 6.80 - 7.8361 Jun 09, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ERNA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 7.61▼ 7.61▼ 7.61▼ 7.66▼ 10.18▼
MA10 7.95▼ 7.95▼ 7.95▼ 8.88▼ 5.92▲
MA20 9.05▼ 9.30▼ 9.42▼ 10.35▼ 3.15▲
MA50 10.55▼ 10.67▼ 10.90▼ 4.96▲ 2.13▲
MA100 11.59▼ 11.33▼ 10.12▼ 2.75▲ 6.21▲
MA200 11.69▼ 7.92▼ 5.33▲ 2.04▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.127▼ -0.181▼ -0.223▼ -0.839▼ 0.857▲
RSI 24.225▼ 24.232▼ 24.281▼ 44.013▼ 59.211▲
STOCH 4.369▼ 2.311▼ 1.944▼ 3.146▼ 67.897    
WILL %R -97.773▼ -98.674▼ -98.962▼ -100.000▼ -57.666    
CCI -155.755▼ -119.044▼ -98.398     -106.146▼ 43.281    
Latest Filters Detected On ERNA
▲ GAP $ERNA Open Gap Up %5 Set Alert
▲ GAP $ERNA Open Gap Up %3 Set Alert
▲ GAP $ERNA Open Gap Up %2 Set Alert
▼ BREAK $ERNA Price Breaks 10 Days Low Set Alert
CDL $ERNA Marubozu Candlestick Pattern Detected Set Alert
Eterna Therapeutics Inc News
Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring ...
Tuesday, June 09, 2026 05:53 AM
ERNA-101 is the company’s lead cell therapy product, designed to activate and regulate the immune system's response to recognize and attack cancer cells. ERNA-201 is a cell therapy product designed to ...
Ernexa Therapeutics Inc.: Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development
Wednesday, May 27, 2026 07:59 AM
Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease ...
Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development
Wednesday, May 27, 2026 05:25 AM
Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced significant progress in the ...
ERNA historical stock data
date open high low close volume
09/06/26 7.8361 7.8361 6.80 6.80 57,042
08/06/26 7.93 8.05 7.39 7.39 39,975
05/06/26 8.03 8.32 7.65 7.89 36,840
04/06/26 8.00 8.4664 7.59 8.19 59,475
03/06/26 8.21 8.85 8.01 8.01 44,546
02/06/26 9.08 9.10 8.00 8.00 54,537
01/06/26 10.36 10.555 8.75 9.12 93,691
29/05/26 11.43 11.525 10.4744 10.57 51,069
28/05/26 11.01 11.905 10.70 11.66 70,626
27/05/26 11.625 11.625 10.50 11.14 55,121
Quote Details
52wk Low:0.134
52wk High:15.88
Vol:57.04K
Avg Vol(3m):37M
1Y Chng:+257.89%
1M Chng:+3,463.94%
Add to Watch List
More Information
Index US Composite
Market Cap. 8.62M